Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor ? levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma-Reference-Cited by-同舟云学术

Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor ? levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma

Published:2002-10-25 Issue:9 Volume:95 Page:1886-1893
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sedlaczek Pawe?,Frydecka Irena,Gabry? Marian,van Dalen Arie,Einarsson Roland,Har?ozi?ska Antonina

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. The CA 125 tumour-associated antigen: a review of the literature

2. Prognostic Significance of CA 125 and TPS Levels after 3 Chemotherapy Courses in Ovarian Cancer Patients

3. How CA 125 is used in routine clinical practice

4. Preoperative Prediction of Optimal Resectability in Advanced Ovarian Cancer Using CA-125

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma;Scientific Reports;2023-01-27

2. The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours;Journal of Obstetrics and Gynaecology;2022-11-17

3. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination;Frontiers in Endocrinology;2022-04-28

4. Point-of-care detection assay based on biomarker-imprinted polymer for different cancers: a state-of-the-art review;Polymer Bulletin;2022-01-23

5. Affinity-free enrichment and mass spectrometry analysis of the ovarian cancer biomarker CA125 (MUC16) from patient-derived ascites;The Analyst;2021